PAX8 and intrahepatic cholangiocarcinoma: LBC (CytoRich using the SurePathTM method) involving dual ICC with CK7 and PAX8 staining and 3D cluster patterns as a surrogate biomarker can provide information as to the primary origin in patients with malignant ascites of unknown primary origin.